IANTREK IN THE NEWS

The latest updates on our innovative surgical solutions—from clinical milestones to product launches that are transforming interventional glaucoma care.

READ MORE

AlloFlo™ Uveo Achieves Key Milestones Ahead of Launch: 7 Peer-Reviewed Studies & 3,000 U.S. Cases

September 2, 2025
•
10
min read
READ MORE

Iantrek sees $42M fundraising for alternative glaucoma surgery launch

August 20, 2025
•
10
min read
READ MORE

Iantrek Raises $42 Million Series C to Launch AlloFlo™ Uveo, a Breakthrough Interventional Glaucoma Therapy

August 20, 2025
•
10
min read
READ MORE

Iantrek Hits 2,000 Procedures for New Bio-Interventional Technology - AlloFlo Uveo

May 6, 2025
•
10
min read
READ MORE

Iantrek announces positive 2-year results from clinical study of its bio-interventional platform for uveoscleral outflow enhancement

March 21, 2025
•
5
min read
READ MORE

Revolutionary Glaucoma Treatment with Intraocular Lens: Highlights from AGS 2025 - SpyGlass

March 3, 2025
•
10
min read
READ MORE

Innovations in ophthalmology and glaucoma, plus a look at the Iantrek Inc. pipeline

February 10, 2025
•
10
min read
READ MORE

Iantrek appoints Adam Szaronos as CEO

February 4, 2025
•
1
min read
READ MORE

Revolutionizing Glaucoma Treatment: Introducing Iantrek's Innovative Biointerventional Technology

November 24, 2024
•
5
min read
READ MORE

Iantrek announces 1-year clinical results of its bio-interventional technology for uveoscleral outflow enhancement in open-angle glaucoma patients

September 17, 2024
•
10
min read
READ MORE

AAO 2023: Suprachoroidal outflow enhancement without implantable hardware: surgical technique and clinical results of a novel supraciliary MIGS

November 5, 2023
•
10
min read
READ MORE

Glaucoma Visionaries: Sean Ianchulev, MD, MPH

January 1, 2022
•
10
min read